Baxter And Thermo Cardiosystems Race To Market New LVAS Heart Pumps
This article was originally published in The Gray Sheet
Executive Summary
Baxter Medical's lead over Thermo Cardiosystems in the European heart-assist market foreshadows a tough road ahead for TCI as both firms enter the U.S. market following simultaneous FDA approvals Sept. 29. The companies are now gearing up to launch similar portable electric left ventricular assist systems (LVAS) for use as a bridge to heart transplant